Merck sees slightly higher 2007 profit
501273
Merck & Co. on Wednesday maintained its forecast of flat earnings for 2006 and slightly higher 2007 results as the drugmaker grapples with generic competition, sending its shares down about 1.4 percent.
473365
Merck & Co. Inc.  shares could  rise to $70 by 2010 if the drugmaker continues to deliver on  its promise of double-digit earnings growth, Barron's said in  its October 29 edition.
323016
German drugs and chemicals group Merck has reported quarterly earnings that have easily beaten forecasts thanks to strong sales of cancer drug Erbitux and a one-off payment for an alcoholism drug.
420770
Strong sales of new vaccines and treatments help US drugs group Merck unveil a sharp rise in quarterly profits.
275333
Medco Health Solutions Inc. , one of the largest U.S. managers of drug benefits, said on Wednesday that profit rose 29 percent, as higher rates of mail-delivered generic drugs drove better profit margins, and it lifted its full-year earnings forecast.
6179
U.S. drugmaker Wyeth  said on Wednesday it was maintaining its profit forecast for 2007, but added that first-quarter earnings would exceed current Wall Street average estimates of 85 cents per share.
552579
Company earned 60 cents a share, down from 83 cents a year earlier; Vioxx linked to heart attacks. NEW YORK  - Merck &amp; Co.
223652
The 3M Company said on Wednesday that it expected double-digit sales and earnings growth in 2008 and forecast profit slightly above the average Wall Street estimate.
685306
Merck &amp; Co. Inc. (MRK.N: Quote, Profile, Research) , reeling from the recent withdrawal of its Vioxx arthritis drug, on Wednesday said 2005 earnings will decline to
298049
The pharmaceutical company reported a 5 percent increase in fourth-quarter earnings but said growth would slow this year as generic competition picked up.
439056
The generics drugmaker forecasts its 2008 financials.
575186
Merck & Co.  on Thursday said its third-quarter profit fell, hurt by negative effects of the recall last month of its Vioxx arthritis drug.
120706
Merck & Co  on Monday said its third-quarter profit rose sharply, helped by sales of its vaccines and cholesterol drugs, and raised its 2007 profit forecast in view of strong current trends.
331670
Medco Health Solutions Inc  on Tuesday posted higher-than-expected quarterly earnings, helped by sales of generic drugs, and the pharmacy benefit manager boosted its full-year profit forecast.
322293
Merck &amp; Co. Inc. said Wednesday it expects the withdrawal of its Vioxx painkiller from the market to reduce full-year earnings by 50 cents to 55 cents a share.
210616
Merck & Co. Inc., reeling from the recent withdrawal of its Vioxx arthritis drug, said Wednesday it expects 2005 earnings of &#36;2.42 to &#36;2.52 a share -- a decline from expected 2004 results.
439296
Drugmaker Merck & Co. Inc.  boosted its 2007 earnings forecast on Wednesday, citing higher-than-expected sales of multiple products, including its cancer vaccine Gardasil and diabetes drug Januvia.